NCT00103558 2015-10-02Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)BiogenPhase 1/2 Completed31 enrolled
NCT00801060 2015-10-02Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)BiogenPhase 2 Terminated40 enrolled